Embree Financial Group

SEC CIK: 0002020860
Latest filing: Jul 15, 2026

SEC filings (opens in a new tab)

NVO holding history

Novo Nordisk A S in every 13F filed by Embree Financial Group, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVO overview All 13F holders of NVO Full Q2 2026 holdings

Shares (Q3 2025): 0; Sold out in Q3 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q4 2024

Holdings of NVO by Embree Financial Group, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2025	0	$0	0.0%	−8,231−100.0%	Sold out	Holders
Q2 2025	8,231	$568.1K	0.1%	−4,618−35.9%	Reduced	Holders
Q1 2025	12,849	$892.2K	0.1%	−1,213−8.6%	Reduced	Holders
Q4 2024	14,062	$1.21M	0.2%	+14,062	New	Holders